103775-14-0

Directory

103775-14-0 Structure

Identification	Back Directory
[Name] MOEXIPRILAT HYDRATE
[CAS] 103775-14-0
[Synonyms] RS 10029 Moexiprilat Moexipril Related CoMpound A 2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic Acid Hydrate (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]aMino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-3-isoquinolinecarboxylic Acid (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-(phenyl-d5)propyl]aMino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-3-isoquinolinecarboxylic Acid [3S-[2[R(R)],3R]]-2-[2-[(1- Carboxy-3-phenylpropyl)aMino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-3-isoquinolinecarboxylic Acid [3S-[2[R(R)],3R]]-2-[2-[(1- Carboxy-3-(phenyl-d5)propyl)aMino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-diMethoxy-3-isoquinolinecarboxylic Acid
[Molecular Formula] C25H30N2O7
[MDL Number] MFCD00865812
[MOL File] 103775-14-0.mol
[Molecular Weight] 470.51

Chemical Properties	Back Directory
[Appearance] White Crystalline Solid
[Melting point ] 145-1700C
[storage temp. ] Hygroscopic, -20°C Freezer, Under Inert Atmosphere
[solubility ] DMSO: soluble Methanol: soluble

Hazard Information	Back Directory
[Chemical Properties] White Crystalline Solid
[Uses] Analogue of Quinapril
[Uses] Angiotensin converting enzyme (ACE) inhibitor; dimethoxy analog of Quinapril. Antihypertensive.
[References] [1] O EDLING. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.[J]. Journal of Pharmacology and Experimental Therapeutics, 1995, 275 2: 854-863. [2] RYAN T. CAMERON . Chemical informatics uncovers a new role for moexipril as a novel inhibitor of cAMP phosphodiesterase-4 (PDE4)[J]. Biochemical pharmacology, 2013, 85 9: Pages 1297-1305. DOI: 10.1016/j.bcp.2013.02.026 [3] C GROHÉ. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.[J]. Journal of Hypertension, 1998, 16 3: 377-384. DOI: 10.1097/00004872-199816030-00015 [4] VAN EICKELS MARTIN. The influence of oestrogen-deficiency and ACE inhibition on the progression of myocardial hypertrophy in spontaneously hypertensive rats[J]. European Journal of Heart Failure, 2005, 7 7: 1079-1084. DOI: 10.1016/j.ejheart.2005.03.004

Safety Data	Back Directory
[HS Code ] 2933497050

103775-14-0 suppliers list

Company Name:	Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel:	+86-057181025280; +8617767106207 , +8617767106207
Website:	https://www.molcore.com/

Company Name:	Chemsky (shanghai) International Co.,Ltd
Tel:	021-50135380
Website:	www.shchemsky.com

Company Name:	Shanghai EFE Biological Technology Co., Ltd.
Tel:	021-65675885 18964387627
Website:	http://www.efebio.com

Company Name:	Beijing Solarbio Science & Tecnology Co., Ltd.
Tel:	17801761073
Website:	www.solarbio.com

Company Name:	Shenzhen Polymeri Biochemical Technology Co., Ltd.
Tel:	+86-400-002-6226 +86-13028896684;
Website:	https://www.rrkchem.com

Company Name:	Hefei Molake Biotechnology Co., Ltd.
Tel:	0551-66336380 18956014586
Website:	https://www.chemicalbook.com/ShowSupplierProductsList31079/0_EN.htm

Company Name:	Shanghai Beiwanta Biotechnology Co., Ltd.
Tel:	021-67187366 19901745723
Website:	http://www.bwtlab.com/

Company Name:	Santa Cruz Biotechnology Inc
Tel:	021-60936350
Website:	www.scbt.com

Tags:103775-14-0 Related Product Information

51037-30-0 113507-06-5 59277-89-3 103775-10-6 207399-25-5

HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

Login